CrossrefInfokarte
Early On-Treatment Ultrasound Tumor Shrinkage and HER2-Positive Residual Invasive Disease After Neoadjuvant Therapy: A 2-Center Study
Clinical Breast Cancer · 2026-11 · 26 (11) · 48-57
DOI: 10.1016/j.clbc.2026.09.006 ↗Abstract
Kein Abstract verfügbar.
EUVIMED